Medicare will negotiate discounts for each drug ranging from 25% off list price ...
Where do we go from here on digital therapeutics?
The venture capital firm’s experiment is facing hurdles even before it has start...
Some takes and thoughts from @adamfeuerstein on Bluebird Bio’s quest for gene th...
Scientists like Shella Keiholz are beginning to rebel against the unjustifiable ...
A patient community that has endured a series of crushing setbacks may soon get ...
Ferrer has announced that its FAB122 failed to achieve its primary efficacy and ...
Germany’s Federal Ministry of Health has published its evaluation report on the ...
In late 2023, Vertex Pharmaceuticals and CRISPR Therapeutics made history by gai...
Musk announced Neuralink's first sucessful human BCI implant on Sunday, but can ...
Astellas has submitted an sNDA in Japan seeking approval for PADCEV with KEYTRUD...
CMS’ CGT Access Model will see allow the agency to negotiate negotiate pricing a...
The FDA has granted an orphan drug designation to Revolo’s ‘1104, with plans for...
As the UK pharmaceutical sector adopts the VPAG scheme, the question of how this...
The NASA and US Navy-propelled company remains confident, with Defender CEO Barr...
The shelving of Biogen’s troubled Alzheimer’s drug caps a turbulent journey, wit...
